Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2010
06/16/2010CN101284811B Synthetic method for chiral carbocyclic ring intermediate of abacavir
06/16/2010CN101099286B Method and installation means for installing an electrical machine
06/15/2010US7737627 OLED/organic light emitters using a compound of 9,9-dimethylfluorenes anda ring such as carbazole for electrical stabity; glass transition temperature; crystal growth inhibiters; low voltage; current density; industrial scale; charge transfer/generating compounds; color dopes
06/15/2010US7737295 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis, antiinflammatory agent; synergistic mixture with other active ingredients
06/15/2010US7737235 Vinyl monomer and polymer derived from the monomer, and light emitting device using the polymer
06/15/2010US7737209 Rubber composition and tire using same
06/15/2010US7737174 6-Chloro-N-3,4-dihydroxybutyl)-5-fluoro-4'-(4-fluorophenyl)-2'-neopentyl-2-oxyspiro[indoline-3,3'-pyrrolidine]-5'-carboxamide; antagonists of the interaction p53 and MDM2 proteins; anticarcinogenic, -proliferative agents; side effect protection of cancer therapy; sensitizers to apoptosis inducers
06/15/2010US7737173 1-Benzyl-5-hydroxy-2-methyl-1H-indole-3-carboxylic Acid, 3,5-Difluorobenzylamide, useful for treating vision defects, angiogenesis, cardiovascular disorders and as wound healing agents
06/15/2010US7737172 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections
06/15/2010US7737171 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737170 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737169 as caged compounds from which effector species such as neurotransmitters and amino acids are releasable on irradiation with light
06/15/2010US7736534 Phosphorescent compositions and organic light emitting devices containing them
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2441309C Biguanide derivatives
06/15/2010CA2379103C Novel spiro compounds
06/15/2010CA2351714C Semi-hydrochloride of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
06/10/2010WO2010065936A1 High penetration compositions and their applications
06/10/2010WO2010065743A2 Bicyclic compounds and methods of making and using same
06/10/2010WO2010064871A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/10/2010WO2010063953A2 Novel amino c-xyloside compounds, and cosmetic use
06/10/2010WO2010063378A1 Geminal alkoxy/alkylspirocyclic substituted tetramic acid derivates
06/10/2010WO2009157018A9 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
06/10/2010US20100145069 Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.1.0]- hexane compounds utilizing bisulfite intermediate
06/10/2010US20100145068 Dendritic Photoactive Compound Comprising Oxime Ester And Method For Preparing The Same
06/10/2010US20100145067 Novel carbazoles derivative and use thereof
06/10/2010US20100145060 Schwartz Reagents: Methods of In Situ Generation and Use
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145036 Chemical linkers and cleavable substrates and conjugates thereof
06/10/2010US20100144825 Renin Inhibitors
06/10/2010US20100144824 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144821 Compounds and methods for treating protein folding disorders
06/10/2010US20100144726 Novel indolic derivatives, their preparation processes and their uses in particular as antibacterials
06/10/2010US20100140603 Blue light emitting compound and organic light emitting diode device comprising the same
06/10/2010CA2745206A1 High penetration compositions and their applications
06/10/2010CA2745006A1 Geminal alkoxy/alkylspirocyclic substituted tetramic acid derivates
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010CA2744152A1 Inhibitors of diacylglycerol acyltransferase
06/09/2010EP2194043A2 Processes and intermediates
06/09/2010EP2194042A2 Methods and systems for increasing production of equilibrium reactions
06/09/2010EP2193118A2 Piperidine and piperazine derivatives for treating tumours
06/09/2010EP2097374B1 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
06/09/2010EP1740171B1 Indol-1-yl-acetic acid derivatives
06/09/2010EP1730110B1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
06/09/2010CN1982309B Industrial synthesis method for producing tropenol
06/09/2010CN1910174B Indolylmaleimide derivatives
06/09/2010CN1910173B Indolylmaleimide derivatives as PKC inhibitors
06/09/2010CN1840607B Complexes of form l2mx as phosphorescent dopants for organic LEDs
06/09/2010CN101730681A Naphthyl carbazole derivatives, kl host material, the organic light emitting device employing the same, the display device and the illumination device employing the same
06/09/2010CN101730680A 4' substituted compounds having 5-ht6 receptor affinity
06/09/2010CN101723876A Anthracene derivative and light-emitting devices, electronic devices, and lighting device using the anthracene derivative
06/09/2010CN101723875A Light trigger
06/09/2010CN101723874A Cyanine compound and application thereof in dyeing biological samples
06/09/2010CN101723873A 2-aryl vinyl indole compounds
06/09/2010CN101723835A Synthesis of 1,2-diarylethene compound
06/08/2010US7732622 Naphthalene derivatives
06/08/2010US7732621 Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid
06/08/2010US7732620 Process for crystallization of Ramipril and preparation of a hydrated form thereof
06/08/2010US7732619 Stilbene derivatives, light-emitting element, display device, and electronic device
06/08/2010US7732480 Bicyclic compounds as modulators of androgen receptor function and method
06/08/2010US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis
06/03/2010WO2010062927A2 Novel substituted octahydrocyclopenta(c)pyrrol-4-amines as calcium channel blockers
06/03/2010WO2010062221A1 Substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids and ethers thereof and the use of same to treat viral diseases
06/03/2010WO2010062107A1 Organic electroluminscent device using electroluminescent compounds
06/03/2010WO2010061989A1 Organometallic complex compounds for photoelectric device and photoelectric device including the same
06/03/2010WO2010061862A1 Antitumor agent containing thalidomide derivative as active ingredient
06/03/2010WO2010061625A1 Novel compound and utilization of same
06/03/2010WO2010061074A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010WO2010060702A1 Photoinitiator mixtures
06/03/2010WO2010060214A1 Hybrid -ionone and curcumin molecules as anticancer agents
06/03/2010US20100137616 Indole compounds useful as serotonin selective agents
06/03/2010US20100137615 Homogeneous Asymmetric Hydrogenation Process
06/03/2010US20100137599 Process for preparing 1,4-butandiol monitrate
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137401 2-methylprop anamides and their use as pharmaceuticals
06/03/2010US20100137400 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
06/03/2010US20100137363 Substituted Indoles And Methods Of Their Use
06/03/2010US20100137301 Substituted Indolealkanoic Acids
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137270 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/03/2010US20100136620 Soluble, stable form of hdm2, crystalline forms thereof and methods of use thereof
06/03/2010US20100136567 Cyanine dyes
06/03/2010US20100136491 Oxime ester photoinitiators
06/03/2010US20100133519 Arylamine compounds and electronic devices
06/03/2010CA2744360A1 Hybrid -ionone and curcumin molecules as anticancer agents
06/03/2010CA2744178A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010CA2742350A1 Novel substituted octahydrocyclopenta(c)pyrrol-4-amines as calcium channel blockers
06/02/2010EP2190808A1 Leukotriene b4 inhibitors
06/02/2010EP2190534A1 Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
06/02/2010EP1608650B1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents
06/02/2010EP1553937B1 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv
06/02/2010EP1541553B1 Indoline compound and medicinal use thereof
06/02/2010EP1483228B1 Nk1 antagonists
06/02/2010CN1840530B Process for preparing pemetrexed
06/02/2010CN1712404B Purification of porphyrin medicine
06/02/2010CN101720315A Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
06/02/2010CN101717362A Novel light initiator
06/02/2010CN101717361A Diazo naphthoquinone sulphonate sensitizer containing protecting groups capable of acid decomposition, and synthesis method thereof
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 458